Boston Scientific Corp (BSX)vsSemler Scientific Inc (SMLR)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
SMLR
Semler Scientific Inc
$20.33
0.00%
HEALTHCARE · Cap: $348.27M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 46608% more annual revenue ($20.07B vs $42.98M). SMLR leads profitability with a 86.2% profit margin vs 14.4%. SMLR trades at a lower P/E of 5.0x. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
SMLR
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Margin of Safety
+90.5%
Fair Value
$213.41
Current Price
$20.33
$193.08 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 86 of every $100 in revenue as profit
Earnings expanding 3570.1% YoY
Areas to Watch
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
Revenue declined 43.2%
Negative free cash flow — burning cash
Operating margin of -25.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : SMLR
The strongest argument for SMLR centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 86.2% and operating margin at -25.0%.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : SMLR
The primary concerns for SMLR are Market Cap, Revenue Growth, Free Cash Flow.
Key Dynamics to Monitor
BSX profiles as a growth stock while SMLR is a declining play — different risk/reward profiles.
SMLR carries more volatility with a beta of 1.33 — expect wider price swings.
BSX is growing revenue faster at 15.9% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 53/100) and 15.9% revenue growth. SMLR offers better value entry with a 90.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Semler Scientific Inc
HEALTHCARE · MEDICAL DEVICES · USA
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that help healthcare providers evaluate and treat patients with chronic conditions in the United States. The company is headquartered in Santa Clara, California.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?